مقالات در نشریات
- ۱. Shojaeian F., Haghighat S., Abbasvandi F., (...), Nafissi N., Najafi S.،Refractory and Recurrent Idiopathic Granulomatous Mastitis Treatment: Adaptive, Randomized Clinical Trial،Journal of the American College of Surgeons،۲۰۲۴ ۶ ۱.
- ۲. Najafi, S., Ansari, M., Omidi, Z., (...), Najafi, N., Haghighat,،Efficacy and safety of diphereline ۱۱.۲۵ mg, microrelin ۱۱.۲۵ mg, and microrelin ۳.۷۵ mg in premenopausal patients with breast cancer: a non-inferiority randomized clinical trial،BMC Cancer,،۲۰۲۳ ۱۲ ۱.
- ۳. Sari, F., Raei, N., Najafi, S., (...), Moghadam, S., Olfatbakhsh, A.،Idiopathic Granulomatous Mastitis: An institutional Experience from a Referral Center،Archives of Breast Cance،۲۰۲۲ ۷ ۱.
- 4. Nazeri, E., Parniani, M., Olfatbakhsh, A., (...), Halvaei, S., Esmaeili, R.,Evaluation of PIK3CA Gene Mutations in Breast Cancer Patients Treated by Trastuzumab,Archives of Breast Cancer,2023 8 1.
- 5. Nazeri, E., Parniani, M., Olfatbakhsh, A., (...), Halvaei, S., Esmaeili, R.,Evaluation of PIK3CA Gene Mutations in Breast Cancer Patients Treated by Trastuzumab,Archives of Breast Cancer,,2023 8 1.
- 6. Choupani, E., Gomari, M.M., Zanganeh, S., (...), Saraygord ,& Afshari, N., Hosseini, A.,Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review,Pharmacological Reviews,,2023 3 1.
- 7. Zand, N., Najafi, S., Fateh, M., (...), Mahdavi, H., Shirkavand, A.,Non-thermal CO2 Laser Therapy (NTCLT): A Novel Photobiomodulative Approach for Immediate Pain Relief of Patchy Oral Mucositis Due to Chemotherapy of Solid Tumors,Journal of Lasers in Medical Sciences,,2023.
- 8. Allahyari, A., Ehsanpour, A., Ansarinejad, N., (...), Kafi, H., Najafi, S.,Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial,BMC Cancer,2022 12 1.
- 9. Allahyari, A., Ehsanpour, A., Najafi, B., (...), Kaf, H., Najaf, S.,Correction: Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial (BMC Cancer, (2022), 22, 1, (960), 10.1186/s12885-,BMC Cancer,,2022 12 1.
- 10. Nazari, A., Lopez ,& Valcarcel, B.G., Najafi, S.,Preferences of Patients With HR+ & HER2- Breast Cancer Regarding Hormonal and Targeted Therapies in the First Line of Their Metastatic Stage: A Discrete Choice Experiment,Value in Health Regional Issues,2021 9 1.
- 11. Raji Lahiji, M., Zarrati, M., Najafi, S., (...), Raji Lahiji, M., Shidfar, F.,Effects of synbiotic supplementation on serum adiponectin and inflammation status of overweight and obese breast cancer survivors: a randomized, triple-blind, placebo-controlled trial,Supportive Care in Cancer,,2021 7 1.
- 12. Raji Lahiji, M., Najafi, S., Janani, L., (...), Razmpoosh, E., Zarrati, M.,The effect of synbiotic on glycemic profile and sex hormones in overweight and obese breast cancer survivors following a weight-loss diet: A randomized, triple-blind, controlled trial,Clinical Nutrition,2021 2 1.
- 13. Najafi, S., Ansari, M., Kaveh, V., Haghighat, S.,Comparing the efficacy and side-effects of PDLASTA® (Pegfilgrastim) with PDGRASTIM® (Filgrastim) in breast cancer patients: a non-inferiority randomized clinical trial,BMC Cancer,2021 12 1.
- 14. Najafi, S., Heidarali, Z., Rajabi, M., (...), Salehi, M., Haghighat, S.,Lithium and preventing chemotherapy-induced peripheral neuropathy in breast cancer patients: a placebo-controlled randomized clinical trial,Trials,2021 12 1.
- 15. Rezvani, H., Mortazavizadeh, S.M., Allahyari, A., (...), Karbalaeian, M., Salari, S.,Efficacy and Safety of Proposed Bevacizumab Biosimilar BE1040V in Patients With Metastatic Colorectal Cancer: A Phase III, Randomized, Double-blind, Noninferiority Clinical Trial,Clinical Therapeutics,2020 5 1.
- 16. Baji, Z., Shakerinejad, Gh., Tehrani, M., Jarvandi, F., Najaf, S.H.,Predicting the determinants of nutritional behaviors among high school female students: The application of extended theory of reasoned action,Journal of Education and Community Health,,2020 3 1.
- 17. Najafi, S., Sadeghi, M., Shajari, M.R., Abasvandi, F., Mohebi, K.,The impact of hormone receptor status on survival and recurrence of HER2-positive breast cancers in standard adjuvant setting: A retrospective study in Tehran, Iran,Journal of the Pakistan Medical Association,2020 1 1.
- 18. Abdollahi, R., Najafi, S., Razmpoosh, E., (...), Cheshmazar, E., Zarrati, M.,The Effect of Dietary Intervention Along with Nutritional Education on Reducing the Gastrointestinal Side Effects Caused by Chemotherapy Among Women with Breast Cancer,Nutrition and Cancer,,2019 8 18.
- 19. Najafi, S., Haghighat, S., Raji Lahiji, M., (...), Asgari, M., Zarrati, M.,Randomized Study of the Effect of Dietary Counseling During Adjuvant Chemotherapy on Chemotherapy Induced Nausea and Vomiting, and Quality of Life in Patients With Breast Cancer,Nutrition and Cancer,,2019 5 19.
- 20. Sharif ,& Kashani, B., Motlagh, A.G., Mafi, A.R., (...), Taghizadeh, A., Najafi, S.,The incidence of deep vein thrombosis in breast cancer patients receiving outpatient cancer therapy in Iran,Tanaffos,2019.
نمایش ۱ تا ۲۰ مورد از کل ۳۶ مورد.